150 related articles for article (PubMed ID: 35044808)
21. Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma.
Ebata T; Yonemori K; Nishikawa T; Sudo K; Shimomura A; Noguchi E; Fujiwara Y; Kato T; Hasegawa K; Fujiwara K; Tamura K
Oncology; 2020; 98(10):699-705. PubMed ID: 32526764
[TBL] [Abstract][Full Text] [Related]
22. [An exceptional venous pattern in a patient with cancer].
Franken MD; Röckmann-Helmbach H; Bijlsma RM
Ned Tijdschr Geneeskd; 2023 Apr; 167():. PubMed ID: 37078574
[TBL] [Abstract][Full Text] [Related]
23. [A case of metastatic choriocarcinoma responding to combination chemotherapy with paclitaxel and carboplatin].
Shimamoto K; Inatomi S; Fujimoto H; Sumioki H
Gan To Kagaku Ryoho; 2010 May; 37(5):943-6. PubMed ID: 20495335
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay.
Matsuo K; Bond VK; Im DD; Rosenshein NB
Am J Clin Oncol; 2010 Aug; 33(4):358-63. PubMed ID: 19875949
[TBL] [Abstract][Full Text] [Related]
25. Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey.
Kucukoztas N; Dizdar O; Rahatli S; Dursun P; Yalcin S; Altundağ Ö; Ozen O; Reyhan NH; Tarhan C; Yildiz F; Ayhan A
Asian Pac J Cancer Prev; 2013; 14(5):2959-62. PubMed ID: 23803061
[TBL] [Abstract][Full Text] [Related]
26. Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature.
Brackmann M; Stasenko M; Uppal S; Erba J; Reynolds RK; McLean K
BMC Cancer; 2018 Feb; 18(1):172. PubMed ID: 29426293
[TBL] [Abstract][Full Text] [Related]
27. [A case of remission of recurrent carcinosarcoma of the uterus with massive ascites by carboplatin].
Takada S; Tamura A; Hiraoka K; Ogino M; Mori H; Imamura T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1253-6. PubMed ID: 7661577
[TBL] [Abstract][Full Text] [Related]
28. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report.
Kahraman K; Ortac F; Kankaya D; Aynaoglu G
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):89-92. PubMed ID: 22482976
[TBL] [Abstract][Full Text] [Related]
29. Are we there yet?
Edmonson JH
Gynecol Oncol; 2000 Nov; 79(2):145-6. PubMed ID: 11063635
[No Abstract] [Full Text] [Related]
30. Primary peritoneal carcinosarcoma: A report of two cases.
Fu HS; Wu YC; Chen CH; Liu WM; Cheng CJ; Chang CW; Wang ID; Chiu YH
Taiwan J Obstet Gynecol; 2019 Mar; 58(2):288-291. PubMed ID: 30910155
[TBL] [Abstract][Full Text] [Related]
31. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
Hensley ML
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
[TBL] [Abstract][Full Text] [Related]
33. A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
Ang JE; Shah RN; Everard M; Keyzor C; Coombes I; Jenkins A; Thomas K; A'Hern R; Jones RL; Blake P; Gabra H; Hall G; Gore ME; Kaye SB
Ann Oncol; 2009 Nov; 20(11):1787-93. PubMed ID: 19542250
[TBL] [Abstract][Full Text] [Related]
34. [Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases].
Otsuka I; Takaya H; Takagi K; Tanaka A; Kaseki H; Izuta C; Sato M; Matsuura T; Suzuki Y
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1249-53. PubMed ID: 24047791
[TBL] [Abstract][Full Text] [Related]
35. Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression.
Carrara L; Guzzo F; Roque DM; Bellone S; Emiliano C; Sartori E; Pecorelli S; Schwartz PE; Rutherford TJ; Santin AD
Gynecol Oncol; 2012 Apr; 125(1):231-6. PubMed ID: 22209775
[TBL] [Abstract][Full Text] [Related]
36. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
Homesley HD; Filiaci V; Markman M; Bitterman P; Eaton L; Kilgore LC; Monk BJ; Ueland FR;
J Clin Oncol; 2007 Feb; 25(5):526-31. PubMed ID: 17290061
[TBL] [Abstract][Full Text] [Related]
37. [Uterine carcinosarcoma].
Serkies K; Jassem J
Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.
Curtin JP; Blessing JA; Soper JT; DeGeest K
Gynecol Oncol; 2001 Nov; 83(2):268-70. PubMed ID: 11606082
[TBL] [Abstract][Full Text] [Related]
39. Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft.
Glaser G; Weroha SJ; Becker MA; Hou X; Enderica-Gonzalez S; Harrington SC; Haluska P
PLoS One; 2015; 10(5):e0126867. PubMed ID: 25962155
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]